Abbott announced today that the U.S. Food and Drug Administration (FDA) has cleared the FreeStyle® Libre 2 iOS application for use with compatible iPhones1, providing a comprehensive digital
Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes - Apr 27, 2022
Download the FreeStyle Libre 2 App & LibreLink App
Download the FreeStyle Libre 2 App & LibreLink App
Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
2 Million Patients And Beyond: Abbott's FreeStyle Libre 2 Cleared In The U.S. For Adults And Children With Diabetes
FreeStyle Libre 2 - US by Abbott Labs
FreeStyle Libre 2 - US on the App Store
Abbott's FreeStyle Libre 2 app snags FDA clearance to help users manage diabetes
Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards - Jun 15, 2020
Download the FreeStyle Libre 2 App & LibreLink App